Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL423P is a **processed pseudogene** derived from the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP) complex[1][3][5][9]. The functional 7SL RNA is essential for targeting secretory proteins to the endoplasmic reticulum, but RN7SL423P is a truncated, non-coding DNA sequence with high similarity to 7SL RNA, generated through retrotransposition[3][5]. Like other pseudogenes, RN7SL423P is presumed non-functional and is not known to be translated or to participate in SRP function. Some studies on pseudogenes suggest generic regulatory roles (as miRNA decoys or in chromatin modulation), but such roles have not been specifically demonstrated for RN7SL423P[4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 423, pseudogene (RN7SL423P).